Theodore Alan Huizenga, SVP, Chief Accounting Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 1,433 shares at $45.65 ($65K) on 2023-03-01, disclosed to the SEC on 2023-03-03.
Seasonal sale ($65k) by SVP, Chief Accounting Officer — this insider has traded RARE in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.65 | 100 | $5K | 7.0% |
| 2 | $45.65 | 1,333 | $61K | 93.0% |
| Total | $45.65 avg | 1,433 | $65K | 100% |
| Filing → |
| RARE | SELL | 2026-03-03 | $37K | — | Filing → |
| RARE | SELL | 2025-12-30 | $3K | — | Filing → |
| RARE | SELL | 2025-09-19 | $2K | — | Filing → |